XRF 1.57% $1.62 xrf scientific limited

Ann: Appendix 4D - Half-Year Report, page-3

  1. 1,707 Posts.
    lightbulb Created with Sketch. 169
    Post-COVID recovery is underway for XRF. All three divisions (consumables, precious metals, capital equipment) grew revenues versus the June half. Company looks on track to return to year-over-year growth in the second half. M&A now a possibility based on disclosure in the presentation.

    And despite all this good news the stock remains incredibly cheap - somewhere around a 10x P/E ratio.
 
watchlist Created with Sketch. Add XRF (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.